Yuuki Kurebayashi

Prof. Yuuki Kurebayashi


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YKYuuki Kurebayashi
Yuuki Kurebayashi
TTTadanobu Takahashi
Tadanobu Takahashi
CTChihiro Tamoto
Chihiro Tamoto
KSKeiji Sahara
Keiji Sahara
TOTadamune Otsubo
Tadamune Otsubo
TSTakashi Suzuki
Takashi Suzuki
Influenza A and B viruses possess a neuraminidase protein that shows sialidase activity. Influenza virus-specific neuraminidase inhibitors (NAIs) are commonly used for clinical treatment of influenza. However, some influenza A and B viruses that are resistant to NAIs have emerged in nature. NAI-resistant viruses have been monitored in public hygiene surveys and the mechanism underlying the resistance has been studied. Here, we describe a new assay for selective detection and isolation of an NAI-resistant virus in a speedy and easy manner by live fluorescence imaging of viral sialidase activity, which we previously developed, in order to achieve high-efficiency capture of an NAI-resistant virus. An NAI-resistant virus maintains sialidase activity even at a concentration of NAI that leads to complete deactivation of the virus. Infected cells and focuses (infected cell populations) of an oseltamivir-resistant virus were selectively visualized by live fluorescence sialidase imaging in the presence of oseltamivir, resulting in high-efficiency isolation of the resistant viruses. The use of a combination of other NAIs (zanamivir, peramivir, and laninamivir) in the imaging showed that the oseltamivir-resistant virus isolated in 2008 was sensitive to zanamivir and laninamivir but resistant to peramivir. Fluorescence imaging in the presence of zanamivir also succeeded in selective live-cell visualization of cells that expressed zanamivir-resistant NA. Fluorescence imaging of NAI-resistant sialidase activity will be a powerful method for study of the NAI resistance mechanism, for public monitoring of NAI-resistant viruses, and for development of a new NAI that shows an effect on various NAI-resistant mutations.

Verified
Journal Article
Open access
PDF file
Akira MinamiAkira Minami
Akira Minami
YKYuuki Kurebayashi
Yuuki Kurebayashi
TTTadanobu Takahashi
Tadanobu Takahashi
TOTadamune Otsubo
Tadamune Otsubo
KIKiyoshi Ikeda
Kiyoshi Ikeda
TSTakashi Suzuki
Takashi Suzuki
Sialidase cleaves sialic acid residues from glycans such as glycoproteins and glycolipids. In the brain, desorption of the sialic acid by sialidase is essential for synaptic plasticity, learning and memory and synaptic transmission. BTP3-Neu5Ac has been developed for sensitive imaging of sialidase enzyme activity in mammalian tissues. Sialidase activity in the rat hippocampus detected with BTP3-Neu5Ac increases rapidly by neuronal depolarization. It is presumed that an increased sialidase activity in conjunction with neural excitation is involved in the formation of the neural circuit for memory. Since sialidase inhibits the exocytosis of the excitatory neurotransmitter glutamate, the increased sialidase activity by neural excitation might play a role in the negative feedback mechanism against the glutamate release. Mammalian tissues other than the brain have also been stained with BTP3-Neu5Ac. On the basis of information on the sialidase activity imaging in the pancreas, it was found that sialidase inhibitor can be used as an anti-diabetic drug that can avoid hypoglycemia, a serious side effect of insulin secretagogues. In this review, we discuss the role of sialidase in the brain as well as in the pancreas and skin, as revealed by using a sialidase activity imaging probe. We also present the detection of influenza virus with BTP3-Neu5Ac and modification of BTP3-Neu5Ac.

2 September 2019 in Polymer Chemistry
Verified
Journal Article
Closed access
PDF file
TTTomonari Tanaka
Tomonari Tanaka
KNKeita Nakashima
Keita Nakashima
STSotaro Tsuji
Sotaro Tsuji
XHXiaoyu Han
Xiaoyu Han
JZJianxin Zhao
Jianxin Zhao
TSTakashi Suzuki
Takashi Suzuki
Glycopolymers bearing complex-type sialylglycopeptides (SGPs) were synthesized using polymers with pendant-activated esters, poly(N-succinimidyl acrylate)s (polyNSAs), and SGP in which N-acetylneuraminic acids were presented at the nonreducing ends. The SGP-grafted copolymers were synthesized successfully by post-polymerization modification of an amino group of SGP with N-succinimidyl esters on the polyNSAs, with different degrees of polymerization (DPs) and degrees of substitution (DSs) of SGP. The resulting glycopolymers bearing SGPs exhibited strong interaction with the corresponding lectin Sambucus sieboldiana agglutinin with higher association constant (Ka) values of the order of 107 M−1. Moreover, the glycopolymers bearing SGPs interacted strongly with the human influenza A virus because of the multivalency of the oligosaccharide moieties on the polymer backbone. Their binding affinities increased with increasing DP and DS of SGP. The glycopolymers did not potentially induce cytotoxicity in the cells.

23 May 2024 in Viruses
Verified
Journal Article
Open access
PDF file
BJBat-Erdene Jargalsaikhan
Bat-Erdene Jargalsaikhan
MMMasanaga Muto
Masanaga Muto
YBYoungeun Been
Youngeun Been
SMShoma Matsumoto
Shoma Matsumoto
EOEiichi Okamura
Eiichi Okamura
MEMasatsugu Ema
Masatsugu Ema
A gene delivery system utilizing lentiviral vectors (LVs) requires high transduction efficiency for successful application in human gene therapy. Pseudotyping allows viral tropism to be expanded, widening the usage of LVs. While vesicular stomatitis virus G (VSV-G) single-pseudotyped LVs are commonly used, dual-pseudotyping is less frequently employed because of its increased complexity. In this study, we examined the potential of phenotypically mixed heterologous dual-pseudotyped LVs with VSV-G and Sendai virus hemagglutinin-neuraminidase (SeV-HN) glycoproteins, termed V/HN-LV. Our findings demonstrated the significantly improved transduction efficiency of V/HN-LV in various cell lines of mice, cynomolgus monkeys, and humans compared with LV pseudotyped with VSV-G alone. Notably, V/HN-LV showed higher transduction efficiency in human cells, including hematopoietic stem cells. The efficient incorporation of wild-type SeV-HN into V/HN-LV depended on VSV-G. SeV-HN removed sialic acid from VSV-G, and the desialylation of VSV-G increased V/HN-LV infectivity. Furthermore, V/HN-LV acquired the ability to recognize sialic acid, particularly N-acetylneuraminic acid on the host cell, enhancing LV infectivity. Overall, VSV-G and SeV-HN synergistically improve LV transduction efficiency and broaden its tropism, indicating their potential use in gene delivery.

1 August 2024 in Glycobiology
Verified
Journal Article
Closed access
PDF file
TTTadanobu Takahashi
Tadanobu Takahashi
YKYuuki Kurebayashi
Yuuki Kurebayashi
TOTadamune Otsubo
Tadamune Otsubo
KIKiyoshi Ikeda
Kiyoshi Ikeda
KKKobun Konagaya
Kobun Konagaya
Hideyuki TakeuchiHideyuki Takeuchi
Hideyuki Takeuchi
The prevalent human pathogen, mumps virus (MuV; orthorubulavirus parotitidis) causes various complications and serious sequelae, such as meningitis, encephalitis, deafness, and impaired fertility. Direct-acting antivirals (DAAs) targeting MuV which can prevent mumps and mumps-associated complications and sequelae are yet to be developed. Paramyxoviridae family members, such as MuV, possess viral surface hemagglutinin-neuraminidase (HN) protein with sialidase activity which facilitates efficient viral replication. Therefore, to develop DAAs targeting MuV we synthesized MuV sialidase inhibitors. It is proposed that the viral HN has a single functional site for N-acetylneuraminic acid (Neu5Ac) binding and sialidase activity. Further, the known MuV sialidase inhibitor is an analog of Neu5Ac—2,3-didehydro-2-deoxy-N-acetylneuraminic acid (DANA)—which lacks potency. DANA derivatives with higher MuV sialidase inhibitory potency are lacking. The MuV-HN–Neu5Ac binding site has a hydrophobic cavity adjacent to the C4 position of Neu5Ac. Exploiting this, here, we synthesized DANA derivatives with increasing hydrophobicity at its C4 position and created 3 novel sialidase inhibitors (Compounds 1, 2 and 3) with higher specificity for MuV-HN than DANA; they inhibited MuV replication step to greater extent than DANA. Furthermore, they also inhibited hemagglutination and the MuV infection step. The insight—that these 3 novel DANA derivatives possess linear hydrocarbon groups at the C4-hydroxyl group of DANA—could help develop highly potent sialidase inhibitors with high specificity for MuV sialidase, which may function as direct-acting MuV-specific antivirals.

6 April 2023 in Molecules
Verified
Journal Article
Open access
PDF file
YKYuuki Kurebayashi
Yuuki Kurebayashi
Hideyuki TakeuchiHideyuki Takeuchi
Hideyuki Takeuchi
Protein glycosylation is a general post-translational modification pathway that controls various biological functions including protein trafficking, cell adhesion, and protein-ligand interaction